Alpha 2.0
Login Register
» Authors » Dima Avramov

Dima Avramov

Explore the profile of Dima Avramov including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 120
Followers 0
Related Specialties
Public Health
General Medicine
Biology
Top 10 Co-Authors
Richard Jarvis
Peter Inglesby
Sam Harper
Nasreen Parkes
Shaun OHanlon
Amir Mehrkar
Tom Ward
Alex Eavis
Simon Davy
Richard Croker
Published In
Br J Gen Pract
BMJ Med
Thromb Res
Elife
Euro Surveill
Affiliations
Soon will be listed here.
Recent Articles
1.
Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients' primary care records in situ using...
Macdonald O, Green A, Walker A, Curtis H, Croker R, Brown A, et al.
BMJ Ment Health . 2023 Sep; 26(1). PMID: 37714668
Background: The COVID-19 pandemic affected how care was delivered to vulnerable patients, such as those with dementia or learning disability. Objective: To explore whether this affected antipsychotic prescribing in at-risk...
2.
Eleven key measures for monitoring general practice clinical activity during COVID-19: A retrospective cohort study using 48 million adults' primary care records in England through OpenSAFELY
Fisher L, Curtis H, Croker R, Wiedemann M, Speed V, Wood C, et al.
Elife . 2023 Jul; 12. PMID: 37498081
Background: The COVID-19 pandemic has had a significant impact on delivery of NHS care. We have developed the OpenSAFELY Service Restoration Observatory (SRO) to develop key measures of primary care...
3.
Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY: population based, retrospective cohort study of 57 million patients using federated analytics
Fisher L, Hopcroft L, Rodgers S, Barrett J, Oliver K, Avery A, et al.
BMJ Med . 2023 Jun; 2(1):e000392. PMID: 37303488
Objective: To implement complex, PINCER (pharmacist led information technology intervention) prescribing indicators, on a national scale with general practice data to describe the impact of the covid-19 pandemic on safe...
4.
Recording of 'COVID-19 vaccine declined': a cohort study on 57.9 million National Health Service patients' records in situ using OpenSAFELY, England, 8 December 2020 to 25 May 2021
Curtis H, Inglesby P, Mackenna B, Croker R, Hulme W, Rentsch C, et al.
Euro Surveill . 2022 Aug; 27(33). PMID: 35983770
BackgroundPriority patients in England were offered COVID-19 vaccination by mid-April 2021. Codes in clinical record systems can denote the vaccine being declined.AimWe describe records of COVID-19 vaccines being declined, according...
5.
Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY
Fisher L, Speed V, Curtis H, Rentsch C, Wong A, Schultze A, et al.
Thromb Res . 2022 Feb; 211:150-153. PMID: 35168181
No abstract available.
6.
Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients’ primary care records in situ using OpenSAFELY
Curtis H, Inglesby P, Morton C, Mackenna B, Green A, Hulme W, et al.
Br J Gen Pract . 2021 Nov; 72(714):e51-e62. PMID: 34750106
Background: On 8 December 2020 NHS England administered the first COVID-19 vaccination. Aim: To describe trends and variation in vaccine coverage in different clinical and demographic groups in the first...
7.
Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records using OpenSAFELY
Walker A, Mackenna B, Inglesby P, Tomlinson L, Rentsch C, Curtis H, et al.
Br J Gen Pract . 2021 Aug; 71(712):e806-e814. PMID: 34340970
Background: Long COVID describes new or persistent symptoms at least 4 weeks after onset of acute COVID-19. Clinical codes to describe this phenomenon were recently created. Aim: To describe the...